The largest database of trusted experimental protocols

Cd56 magnetic beads

Manufactured by Miltenyi Biotec
Sourced in Germany

CD56 magnetic beads are a laboratory product designed for the isolation and enrichment of CD56-positive cells. These beads are coated with antibodies specific to the CD56 surface antigen, allowing for the efficient capture and separation of CD56-expressing cells from complex samples. The core function of these beads is to facilitate the isolation and purification of CD56-positive cells for a variety of research and clinical applications.

Automatically generated - may contain errors

4 protocols using cd56 magnetic beads

1

Expansion and Activation of Human NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human NK cells were isolated from the peripheral blood of healthy donors using RosetteSep (Stem Cell Technologies, Vancouver, BC, Canada)—which depletes cluster of differentiation 3+ T cells and red blood cells—followed by CD56 magnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany). The cells were cultured in α Minimal Essential Medium (Welgene, Gyeongsan, Korea) with IL-15 (30 ng/ml), IL-21 (30 ng/ml), and 10−6 M of hydrocortisone (HC; Stem Cell Technologies, Canada). To investigate the effect of PGE2 on NK cell toxicity, the cells were cultured for 48 h with either control medium or thyroid cancer cell culture supernatant at 1/4 dilution.
+ Open protocol
+ Expand
2

Nasal T/NK Cell Lymphoma and CAEBV Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
SNT8 was derived from T cell type of Nasal T/NK cell lymphoma. SNK6 was derived from the NK cell type of Nasal T/NK cell lymphoma. SNT15 and SNT16 were derived from T cell type of CAEBV. SNK1 and SNK10 were derived from NK cell type of CAEBV [14 (link)]. They were cultured in Artemis medium-2 (Nihon Techno Service, Ibaragi, Japan) [14 (link)]. A monocytic leukemia cell line, THP-1, was obtained from Health Science Research Resources Bank (Osaka, Japan). Human primary monocytes were obtained from healthy donors using Pan Monocyte Isolation Kit (Miltenyi Biotec, Bergisch Gladbach, Germany). NK-cells were also obtained from healthy donors using CD56 magnetic beads (Miltenyi Biotec).
They were both isolated from their peripheral blood mononuclear cells (PBMC) using lymphoprep (Abbott Diagnostics Technologies AS, Chicago, IL, USA). They were cultured in RPMI-1640 (Wako Pure Chemical Industries, Osaka, Japan) containing 10% fetal bovine serum (Sigma-Aldrich, St. Louis, MO, USA). Recombinant human TNF-α (300-01A), IL-6 (200-06) and IFN-γ (300-02-1) were purchased from PeproTech (East Windsor, NJ, USA). Phorbol 12-myristate 13-acetate (PMA) was purchased from Sigma-Aldrich.
+ Open protocol
+ Expand
3

Isolation of NK Cells from PBMC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ethical approval for collection of blood was obtained from St. Vincent’s University Hospital Ethics Committee. 20 ml. of whole blood was collected from healthy female volunteers in EDTA vacutubes (BD Biosciences). The PBMC fraction was isolated using a Ficoll-Paque plus protocol (GE Healthcare). PBMCs were counted by flow cytometry (Guava Viacount) and re-suspended in ADCC assay medium (RPMI-1640/10% HI FCS/0.1mM penicillin/streptomycin). NK cells were isolated from the PBMC fraction using CD56+ magnetic beads on a midiMACs column according to manufacturer’s protocol (70–90% purity) (Miltenyi Biotec).
+ Open protocol
+ Expand
4

Evaluating NK Cell Cytotoxicity with SAHA-Treated MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effect of SAHA-treated MSC on NK cell function was assessed by BATDA cytotoxicity assays as described previously [34 (link)]. MSCs were seeded into a 24-well plate and treated with 0.1–3.5 μM SAHA or corresponding controls for 48 h. NK cells were isolated by immunomagnetic selection using CD56+ magnetic beads (Miltenyi Biotech, Bergisch Gladbach, Germany) from PBMC of healthy donors. Prior to co-cultivation, SAHA-treated MSCs were washed with PBS (Biochrom, Berlin, Germany). NK cells were co-cultured with MSC at a ratio of 4:1 in the presence of 100 U/mL IL-2 (BD Biosciences, Heidelberg, Germany) where indicated. After four days of co-culture, NK cells were isolated and counted in a Neubauer chamber. The leukemic cell line K562 (ATCC) was used as target cell line. K562 was loaded with BATDA according to the manufacturer`s protocol (DELFIA Cell Cytotoxicity kit, PerkinElmer LAS, Rodgau-Jügesheim, Germany). NK cell cytotoxicity against the leukemic cell line K562 (ATCC, Manassas, VA, USA) was tested in triplicates. Effector cells and target cells were incubated for 2 h. Maximum lysis was reached using DELFIA Lysis buffer (PerkinElmer LAS, Rodgau-Jügesheim, Germany). Specific lysis was calculated using the following formula: % Specific lysis=Lysis by effector cellsspontaneous lysisMaximum lysisspontaneous lysis×100
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!